MIRUM PHARMACEUTICALS
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
MIRUM PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.mirumpharma.com
Total Employee:
11+
Status:
Active
Contact:
650-667-4085
Email Addresses:
[email protected]
Total Funding:
222 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
ACELYRIN
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Adcentrx Therapeutics
Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases
AffaMed Therapeutics
AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Ayala Pharmaceuticals
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
Citius Pharmaceuticals
Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eris Pharmaceuticals
Eris Pharmaceuticals is a dynamic pharmaceutical company focused on the development and marketing of health care products.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
GW Pharmaceuticals
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Lengo Therapeutics
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Outlook Therapeutics
Outlook Therapeutics is a biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics.
OS Therapies
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma.
Paratek Pharmaceuticals
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies.
Pivot Pharmaceuticals
Pivot Pharmaceuticals is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals.
Predictably Human
Predictably Human is a pharmaceutical company that develops digital therapeutics.
PTC Therapeutics
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics.
Rarecells
Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Seelos Therapeutics
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics.
SwanBio Therapeutics
SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oberland Capital
Oberland Capital investment in Post-IPO Equity - Mirum Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Series A - Mirum Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series A - Mirum Pharmaceuticals
RiverVest
RiverVest investment in Series A - Mirum Pharmaceuticals
Pappas Capital
Pappas Capital investment in Series A - Mirum Pharmaceuticals
Novo Holdings
Novo Holdings investment in Series A - Mirum Pharmaceuticals
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Mirum Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Mirum Pharmaceuticals
Chiesi Ventures
Chiesi Ventures investment in Series A - Mirum Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-28 | Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer |
Official Site Inspections
http://www.mirumpharma.com Semrush global rank: 4.47 M Semrush visits lastest month: 2.44 K
- Host name: 165.145.227.35.bc.googleusercontent.com
- IP address: 35.227.145.165
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Mirum Pharmaceuticals"
Leadership Team - Mirum Pharma
Here at Mirum, we have brought together some of the top experts in liver disease and pharmaceutical development. It is with passion, insight, and collective experience that we’re …See details»
About Us - Mirum Pharma
We are committed to developing safe and effective therapies for people with rare liver diseases. Ultimately, we want to help patients and their families experience a brighter future.See details»
Mirum Pharmaceuticals, Inc. - Corporate Responsibility
From early-stage research and clinical trial management to commercialization, our employees’ expertise covers a wide range of disciplines within rare disease and pharmaceutical drug …See details»
Mirum Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 650-667-4085 Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies …See details»
Mirum Pharmaceuticals: Transforming Lives in Rare Disease
Jan 8, 2024 Forward-Looking Statements This presentation contains "forward -looking" statements that are based on our managements beliefs and assumptions and on information …See details»
Mirum Pharmaceuticals, Inc. - Governance Documents
The Board of Directors of Mirum Pharmaceuticals, Inc. (the "Company") sets high standards for the Company's employees, officers and directors.See details»
Mirum Pharmaceuticals: Transforming Lives in Rare Disease
Oct 2, 2023 Building a Leading Growth Franchise in Pediatric Hepatology 1 Based on 2023 six months ended net products sales of $61.6M for LIVMARLI (Mirum Pharmaceuticals, Inc. 10 -Q …See details»
Company Profile for Mirum Pharmaceuticals - Business Wire
Sep 26, 2019 Company: Mirum Pharmaceuticals Headquarters Address: 950 Tower Lane Suite 1050 Foster City, CA 94404 Main Telephone: 650-667-4085See details»
Mirum Pharmaceuticals, Inc. - Investor Relations
Dec 3, 2024 To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address.See details»
Mirum Pharmaceuticals, Inc. (MIRM) - Yahoo Finance
See the company profile for Mirum Pharmaceuticals, Inc. (MIRM) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Joining Mirum - Mirum Pharma
The chance to develop and deliver potentially life-changing and life-saving medicine for a patient community in great need—that’s what makes our work here more than a job.See details»
Who Owns Mirum Pharmaceuticals - CBM
Oct 2, 2024 Website: mirumpharma.com; Focus: Development and commercialization of therapies for rare liver diseases and pediatric conditions; ... the ownership structure is crucial …See details»
Mirum Pharmaceuticals:
Sep 6, 2023 Building a Leading Growth Franchise in Pediatric Hepatology 1 Based on 2023 six months ended net products sales of $61.6M for LIVMARLI (Mirum Pharmaceuticals, Inc. 10-Q …See details»
Company Description - Stock Analysis
Jul 18, 2019 950 Tower Lane, Suite 1050 Foster City, California 94404 United StatesSee details»
Mirum Pharmaceuticals - Craft
Oct 29, 2024 Mirum Pharmaceuticals has 1 employees at their 1 location and $186.37 m in annual revenue in FY 2023. See insights on Mirum Pharmaceuticals including office locations, …See details»
Mirum Pharmaceuticals: Transforming Lives in Rare Disease
Nov 12, 2024 Strong Execution Positions Mirum as a High-Growth, Global Biotech 4 Proven Track Record of Execution and Efficiency 1 Received U.S. FDA approval for cholestatic …See details»
Working at Mirum Pharmaceuticals - Zippia
Mar 14, 2024 mirumpharma.com. Organization Type. Public. Social Media. Developing medicines with the potential to change lives. Creating transformative medicine for rare liver …See details»
The Mirum Experience - Mirum Pharma
At Mirum, we’re proud that our expertise covers a wide range of disciplines within rare disease and pharmaceutical drug development. Our deep experience spans early-stage research, …See details»
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq …
3 days ago To learn more about Mirum, visit mirumpharma.com and follow Mirum on Facebook, LinkedIn, Instagram and Twitter (X). Contacts. Investor Contact: Andrew McKibben …See details»
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024
9 hours ago To learn more about Mirum, visit mirumpharma.com and follow Mirum on Facebook, LinkedIn, Instagram and Twitter (X). Forward-Looking Statements. Statements contained in …See details»